JPWO2020138260A1 - - Google Patents

Info

Publication number
JPWO2020138260A1
JPWO2020138260A1 JP2020562391A JP2020562391A JPWO2020138260A1 JP WO2020138260 A1 JPWO2020138260 A1 JP WO2020138260A1 JP 2020562391 A JP2020562391 A JP 2020562391A JP 2020562391 A JP2020562391 A JP 2020562391A JP WO2020138260 A1 JPWO2020138260 A1 JP WO2020138260A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020562391A
Other languages
Japanese (ja)
Other versions
JP7479636B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020138260A1 publication Critical patent/JPWO2020138260A1/ja
Application granted granted Critical
Publication of JP7479636B2 publication Critical patent/JP7479636B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
JP2020562391A 2018-12-26 2019-12-26 全身性エリテマトーデスの検出方法 Active JP7479636B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018242371 2018-12-26
JP2018242371 2018-12-26
PCT/JP2019/051066 WO2020138260A1 (ja) 2018-12-26 2019-12-26 全身性エリテマトーデスの検出方法

Publications (2)

Publication Number Publication Date
JPWO2020138260A1 true JPWO2020138260A1 (zh) 2020-07-02
JP7479636B2 JP7479636B2 (ja) 2024-05-09

Family

ID=71127740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020562391A Active JP7479636B2 (ja) 2018-12-26 2019-12-26 全身性エリテマトーデスの検出方法

Country Status (5)

Country Link
US (1) US20220120730A1 (zh)
EP (1) EP3904872A4 (zh)
JP (1) JP7479636B2 (zh)
CN (1) CN113227777B (zh)
WO (1) WO2020138260A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023063331A1 (ja) * 2021-10-14 2023-04-20 国立大学法人東海国立大学機構 抗３'，４'－ジデヒドロ－３'－デオキシシチジン抗体

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005511025A (ja) * 2001-09-25 2005-04-28 ザ・ジョーンズ・ホプキンス・ユニバーシティ ハイスループットスクリーニングおよび創薬のための同質遺伝子性ヒト癌細胞の使用方法
WO2013183596A1 (ja) * 2012-06-06 2013-12-12 国立大学法人名古屋大学 腎疾患のバイオマーカー及びその用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8628930B2 (en) * 2009-04-27 2014-01-14 Niigata University Use of megalin in urine as marker for detecting renal disorder
CN104870012A (zh) * 2012-06-27 2015-08-26 吉安特科技公司 用于炎性疾病的抗-cxcl9、抗-cxcl10、抗-cxcl11、抗-cxcl13、抗-cxcr3和抗-cxcr5试剂
JP6128631B2 (ja) 2012-08-01 2017-05-17 国立大学法人名古屋大学 糖尿病性腎症鑑別用マーカー及びその用途
CN105441578B (zh) * 2016-01-19 2018-08-31 中南大学湘雅二医院 尿液外泌体microRNA分子标志物的应用及制备的试剂盒

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005511025A (ja) * 2001-09-25 2005-04-28 ザ・ジョーンズ・ホプキンス・ユニバーシティ ハイスループットスクリーニングおよび創薬のための同質遺伝子性ヒト癌細胞の使用方法
WO2013183596A1 (ja) * 2012-06-06 2013-12-12 国立大学法人名古屋大学 腎疾患のバイオマーカー及びその用途

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
OUYANG, X、外３名: "1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.", LUPUS, vol. 20, no. 13, JPN6020010160, 29 November 2011 (2011-11-29), pages 1411 - 1420, XP008180340, ISSN: 0005184580, DOI: 10.1177/0961203311418707 *
TRITTEN L、外７名: "Metabolic Profiling Framework for Discovery of Candidate Diagnostic Markers of Malaria", SCI REP., vol. 3, no. 2769, JPN6020010159, 26 September 2013 (2013-09-26), pages 1 - 7, ISSN: 0005184579 *
平山明由、外１名: "メタボロミクスを用いた新たな尿検査の可能性", 日本臨床検査自動化学会会誌, vol. 42, no. 2, JPN6020010158, 1 April 2017 (2017-04-01), JP, pages 163 - 166, ISSN: 0005184578 *

Also Published As

Publication number Publication date
JP7479636B2 (ja) 2024-05-09
WO2020138260A1 (ja) 2020-07-02
US20220120730A1 (en) 2022-04-21
CN113227777B (zh) 2024-09-06
CN113227777A (zh) 2021-08-06
EP3904872A1 (en) 2021-11-03
EP3904872A4 (en) 2022-10-19

Similar Documents

Publication Publication Date Title
BR122022006221A2 (zh)
AT524834A2 (zh)
AT524874A5 (zh)
AU2018438767B1 (zh)
JPWO2020138260A1 (zh)
AT524266A2 (zh)
AT521543A3 (zh)
AT524961A5 (zh)
BR122022015550A2 (zh)
BR212020012832U2 (zh)
BR202018071071U8 (zh)
BR102018070765A2 (zh)
BR102018016915A2 (zh)
BE2018C025I2 (zh)
BR102018007062A2 (zh)
CN304434473S (zh)
CN304434154S (zh)
CN304442425S (zh)
CN304439438S (zh)
CN304438173S (zh)
CN304438026S (zh)
CN304435997S (zh)
CN304434491S (zh)
CN304444716S (zh)
CN304434459S (zh)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210621

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231030

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231226

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240325

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240416

R150 Certificate of patent or registration of utility model

Ref document number: 7479636

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150